ABSTRACT: Although quinolones have been in clinical use for decades, the mechanism underlying drug activity and resistance has remained elusive. However, recent studies indicate that clinically relevant quinolones interact with Bacillus anthracis (Gram-positive) topoisomerase IV through a critical water− metal ion bridge and that the most common quinolone resistance mutations decrease drug activity by disrupting this bridge. As a first step toward determining whether the water−metal ion bridge is a general mechanism of quinolone− topoisomerase interaction, we characterized drug interactions with wild-type Escherichia coli (Gram-negative) topoisomerase IV and a series of ParC enzymes with mutations (S80L, S80I, S80F, and E84K) in the predict...
The bacterial topoisomerases Gyrase and Topoisomerase IV are well validated targets in antibiotic re...
Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase I...
The widely used quinolone antibiotics act by trapping prokaryotic type IIA topoisomerases, resulting...
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge
Quinolones, which target gyrase and topoisomerase IV, are the most widely prescribed antibacterials ...
The maintenance of DNA supercoiling is essential for the proper regulation of a plethora of biologic...
Abstract: Quinolones constitute a large class of antibacterial agents whose action is mediated thro...
Quinolones are widely studied antibacterial agents that act by forming a ternary complex with DNA an...
Quinolone antibacterials have been used to treat bacterial infections for over 40 years. A crystal s...
ABSTRACT: Quinolones are one of the most commonly prescribed classes of antibacterials in the world ...
The present review focuses on the structural modifications responsible for the transformation of an ...
Topoisomerase IV is an enzyme that exclusively presents in prokaryotic cells and is mainly responsib...
Since their discovery over five decades ago, quinolone antibiotics have found enormous success as br...
Type II topoisomerases alter DNA topology by forming a covalent DNA-cleavage complex that allows DNA...
As part of a programme of synthesizing and investigating the biological properties of new fluoroquin...
The bacterial topoisomerases Gyrase and Topoisomerase IV are well validated targets in antibiotic re...
Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase I...
The widely used quinolone antibiotics act by trapping prokaryotic type IIA topoisomerases, resulting...
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge
Quinolones, which target gyrase and topoisomerase IV, are the most widely prescribed antibacterials ...
The maintenance of DNA supercoiling is essential for the proper regulation of a plethora of biologic...
Abstract: Quinolones constitute a large class of antibacterial agents whose action is mediated thro...
Quinolones are widely studied antibacterial agents that act by forming a ternary complex with DNA an...
Quinolone antibacterials have been used to treat bacterial infections for over 40 years. A crystal s...
ABSTRACT: Quinolones are one of the most commonly prescribed classes of antibacterials in the world ...
The present review focuses on the structural modifications responsible for the transformation of an ...
Topoisomerase IV is an enzyme that exclusively presents in prokaryotic cells and is mainly responsib...
Since their discovery over five decades ago, quinolone antibiotics have found enormous success as br...
Type II topoisomerases alter DNA topology by forming a covalent DNA-cleavage complex that allows DNA...
As part of a programme of synthesizing and investigating the biological properties of new fluoroquin...
The bacterial topoisomerases Gyrase and Topoisomerase IV are well validated targets in antibiotic re...
Bacterial DNA gyrase and topoisomerase IV are selective targets of fluoroquinolones. Topoisomerase I...
The widely used quinolone antibiotics act by trapping prokaryotic type IIA topoisomerases, resulting...